RxDoctor Payments Data

Robert Sershon, MD

Adult Reconstructive Orthopaedic Surgery · Arlington, VANPI 1346689338

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. Zimmer Biomet accounts for 81.0% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $39,276, 2.7 times the $14,557 reported in 2019.

$94,286in general payments, 2019–2025

Across 230 payments — averaging $409.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$76K
  • Smith+Nephew$7K
  • Medical Device Business Services, Inc.$6K
  • Stryker$4K
  • UOC USA Inc$301
  • Johnson & Johnson$256
  • plus $234 from 6 others
$195,159in research payments, 2019–2025

Across 13 payments — averaging $15,012 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$195K

What the payments were for

  • Consulting fees$55,70259%
  • Travel & lodging$22,25724%
  • Food & beverage$7,1228%
  • Education$9,09010%
  • Gifts$1140%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$94,286 in reported general payments places this provider in the 85th percentile of 58 adult reconstructive orthopaedic surgery providers in Virginia.

See all adult reconstructive orthopaedic surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$744,021
Medicare patients
748
Services billed
5,224

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib153$2,435
Meloxicam20$57

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Arlington

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →